Health Monthly Martinique: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Monthly Martinique.

Press releases published on September 9, 2026

9 hours ago

Rezera Announces Ruvonoflast Met its Primary Inflammation Endpoint and Demonstrated Favorable Safety Profile in RESOLVE-1 Phase 2 Clinical Trial

Indeterminate GlobeNewswire

9 hours ago

ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026

Indeterminate GlobeNewswire

9 hours ago

Jasper Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

9 hours ago

Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates

Indeterminate GlobeNewswire

9 hours ago

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

9 hours ago

IN8bio Appoints Oxana Polyakova, Ph.D., as Senior Vice President of Research & Development

Indeterminate GlobeNewswire

9 hours ago

Callio Therapeutics Appoints Zachary Hornby as Chief Executive Officer

Indeterminate GlobeNewswire

9 hours ago

Jushi Holdings Inc. Announces Open-Market Share Purchases by Chief Executive Officer, Chairman and Founder Jim Cacioppo

Indeterminate GlobeNewswire

9 hours ago

NodThera Inc. Changes Name to Rezera Inc. and Announces Ruvonoflast Phase 3 Development Program

Indeterminate GlobeNewswire

9 hours ago

Quantum-Si Expands Proteus™ Roadshow with Additional U.S. and European Cities

Indeterminate GlobeNewswire

9 hours ago

Aktis Oncology to Present at Upcoming September Investor Conferences

Indeterminate GlobeNewswire

9 hours ago

Starton Therapeutics to Present at the 17th Annual World Bispecific Summit in Boston

Indeterminate GlobeNewswire

9 hours ago

INmune Bio to Present at the H.C. Wainwright Global Investment Conference

Indeterminate GlobeNewswire

9 hours ago

AEON Announces Positive Pilot Forced Degradation Results Supporting Analytical Comparability of ABP-450 to BOTOX®

Indeterminate GlobeNewswire

9 hours ago

electroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers

Indeterminate GlobeNewswire

9 hours ago

Humacyte Announces FDA Authorization Extending Symvess Shelf Life to 36 Months

Indeterminate GlobeNewswire

9 hours ago

Persephone Biosciences Celebrates First Birthday of Bloom and Thrive Synbiotics, with More Than 1.5 Million Doses Manufactured

Indeterminate GlobeNewswire

9 hours ago

MBX Biosciences to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

9 hours ago

UF Health Collaborates with R1 on AI-Powered Revenue Cycle Transformation with Phare OS

Indeterminate GlobeNewswire

9 hours ago

SOTIO Doses First Patient in Phase 1/2 CADENCIA-01 Clinical Trial of SOT109, a CDH17-Targeting ADC for Colorectal Cancer

Indeterminate GlobeNewswire